Additionally, pharmacological inhibition of C5a signaling has been demonstrated to ameliorate diabetic nephropathy in animal models [35, 36], although neither of these studies investigated the effect on renal neutrophil populations. Here, C5AR1 is linked to diabetic kidney disease.